Pustular psoriasis is a rare inflammatory skin condition marked by painful, pus-filled blisters that appear on patches of red, scaly skin, affecting about three percent of people who live with psoriasis—a chronic disease that can resurface throughout a person’s lifetime.
Epidemiology
Pustular psoriasis represents a relatively uncommon variant of psoriasis, occurring in approximately three percent of individuals diagnosed with psoriasis. While this form of the disease can develop at any age, it shows a distinctive pattern in how it affects different groups of people. Among adults, pustular psoriasis most commonly appears in people between forty and fifty years of age, though it remains unusual in children. Interestingly, when the disease does occur in younger individuals—specifically between the ages of three and sixteen—boys appear to be more commonly affected than girls.[1][3]
The distribution of pustular psoriasis varies across different populations. Research suggests that this condition may be more prevalent in certain skin-of-color ethnicities, though the exact reasons for this variation remain under investigation. Women are generally more likely to develop pustular psoriasis than men, although this gender difference reverses in pediatric cases. The condition affects people worldwide, and while psoriasis as a whole impacts millions of individuals in the United States, pustular psoriasis remains one of the rarer manifestations of this broader disease family.[1][2]
Within the pustular psoriasis category, generalized pustular psoriasis—also known as GPP—stands out as the rarest form of all psoriasis types. This severe variant can spread rapidly across large areas of the body and requires immediate medical attention. The age at which pustular psoriasis first appears may be earlier in patients who have a family history of psoriasis or carry specific genetic mutations affecting immune system regulation.[6]
Causes
The exact mechanisms that trigger pustular psoriasis are not fully understood, but the condition arises from a combination of genetic factors and immune system dysfunction. Psoriasis occurs when the immune system becomes overactive, leading to widespread inflammation throughout the body. This overactive immune response dramatically accelerates the growth cycle of skin cells. In healthy skin, cells take about a month to mature and naturally shed from the surface. However, in people with psoriasis, this process speeds up dramatically—skin cells complete their entire cycle in just three or four days.[1][10]
Because skin cells grow so quickly, they cannot shed properly. Instead of flaking away naturally, these cells pile up on the skin’s surface, creating the characteristic thick, scaly patches called plaques. In pustular psoriasis, the immune system also triggers a massive influx of white blood cells called neutrophils to migrate into the skin. These cells accumulate between skin layers, forming pockets of fluid that appear as pustules—the yellowish or whitish bumps filled with what looks like pus. Despite their appearance, these pustules are sterile, meaning they contain no bacteria or infectious agents and cannot spread from person to person.[3][4]
Scientists have identified several genetic mutations strongly associated with pustular psoriasis. Mutations in genes like IL36RN (interleukin 36 receptor antagonist), CARD14, and AP1S3 affect how the immune system regulates inflammation. People who inherit two faulty copies of IL36RN (homozygous mutations) are particularly likely to develop generalized pustular psoriasis without the typical plaque psoriasis that most people with psoriasis experience. These genetic differences help explain why pustular psoriasis runs in families and why some individuals develop this condition while others do not.[6][13]
The inflammation caused by psoriasis extends beyond the skin. It can affect other organs and systems throughout the body, which is why people with psoriasis often develop related health conditions. Understanding psoriasis as a systemic inflammatory disease—rather than just a skin problem—helps explain why treatment focuses on calming the entire immune system, not just clearing visible skin symptoms.[1]
Risk Factors
Several specific factors can trigger or worsen pustular psoriasis episodes, even in people who have been living with the condition without major problems. Certain medications represent one of the most common triggers. Antibiotics such as amoxicillin, antifungal drugs like terbinafine, and medications including lithium (used for mood disorders), potassium iodide, and hydroxychloroquine have all been linked to pustular psoriasis flares. Pain medications, particularly non-steroidal anti-inflammatory drugs (NSAIDs) and morphine, may also provoke episodes in susceptible individuals.[3][6]
One particularly significant risk involves systemic corticosteroids—powerful anti-inflammatory medications often prescribed for severe psoriasis or other conditions. Starting these medications suddenly or, more commonly, stopping them abruptly or tapering them too quickly can trigger a severe flare of pustular psoriasis. Similarly, suddenly discontinuing another immunosuppressive medication called cyclosporin carries the same risk. Because of this danger, doctors carefully manage these medications and advise patients never to stop them without medical supervision.[6][13]
Infections increase the risk of developing pustular psoriasis. Bacterial infections caused by Staphylococcus aureus or Streptococcal species can trigger episodes, as can various viral infections including cytomegalovirus, Epstein-Barr virus, and varicella-zoster virus (which causes chickenpox and shingles). Even fungal infections, particularly those caused by Trichophyton rubrum—the fungus responsible for athlete’s foot and fungal nail infections—have been associated with pustular psoriasis flares.[6]
Pregnancy represents a unique risk period for developing a form of pustular psoriasis called impetigo herpetiformis. This pregnancy-related variant is associated with low calcium levels and infections during pregnancy and carries serious risks for both mother and developing baby. Women who develop pustular psoriasis during pregnancy require immediate specialized medical care.[3][6]
Other risk factors include exposure to ultraviolet radiation from sunlight or tanning beds, particularly sunburns; low blood calcium levels (hypocalcemia), which can occur secondary to hypoparathyroidism; emotional stress; menstruation in women; and certain vaccinations, including those against COVID-19 and H1N1 influenza. Some people have even developed pustular psoriasis following stem cell transplantation. Smoking increases the risk particularly for palmoplantar pustulosis, the form of pustular psoriasis affecting the hands and feet.[4][6]
Having plaque psoriasis—the most common type of psoriasis—represents a significant risk factor for eventually developing pustular psoriasis. The two conditions are strongly associated, and many people with pustular psoriasis either currently have or previously had plaque psoriasis. Additionally, people with pustular psoriasis face an increased risk of developing psoriatic arthritis, a condition that causes joint pain and inflammation. Research indicates that approximately one in three people with psoriasis will develop psoriatic arthritis at some point.[1][6]
Symptoms
The hallmark symptom of pustular psoriasis is the appearance of small, raised bumps filled with fluid that looks like pus. These pustules typically develop on top of or within patches of thick, discolored, flaky, and scaly skin. The pustules themselves are usually white or yellow in color and may be tender or painful to touch. Though they appear infected, they contain sterile fluid composed primarily of white blood cells and inflammatory proteins, not bacteria, which means the condition cannot spread from one person to another through contact.[1][4]
The affected skin around pustules typically appears red or, in people with darker skin tones, may show discoloration appropriate to their complexion. The skin feels inflamed, warm, and tender. Many people experience mild to moderate pain and itching in affected areas. As pustules develop and spread, they can merge together with neighboring fluid-filled bumps, forming larger collections of fluid. When pustules burst open, the skin underneath feels especially tender and sore. The breaking of pustules doesn’t mark the end of symptoms—new pustules frequently form in the same locations, creating a cycle of recurrent blistering.[2][14]
The location and extent of symptoms vary depending on which type of pustular psoriasis a person has. In localized pustular psoriasis, pustules concentrate in specific body areas. The most common form, palmoplantar pustular psoriasis, affects only the palms of the hands and soles of the feet, often targeting the base of the thumbs and sides of the heels. The skin in these areas may crack and peel, making walking or using the hands difficult and painful. Another localized form, acrodermatitis continua of Hallopeau, restricts symptoms to the fingertips and toe tips, particularly around the nails. This variant causes extremely painful lesions that can make everyday tasks involving fine hand movements nearly impossible. In severe cases, it may damage nails or even underlying bone.[1][2]
Generalized pustular psoriasis presents much more dramatically. In this severe form, the skin initially becomes fiery red and extremely tender across wide areas of the body. Within hours, numerous small pustules—typically two to three millimeters in size—erupt across the reddened skin in diffuse patterns or annular (ring-shaped) configurations. These pustules are not associated with hair follicles, distinguishing them from other pustular skin conditions. The rapid spread and intensity of symptoms make generalized pustular psoriasis a medical emergency.[5][13]
Beyond skin symptoms, generalized pustular psoriasis commonly causes systemic problems throughout the body. People with active GPP flares often develop high fever, sometimes accompanied by chills that make them feel alternately burning hot and freezing cold. Severe itching can be overwhelming and constant. Many patients experience profound fatigue and muscle weakness that makes even basic activities exhausting. Additional symptoms may include headache, joint pain (arthralgia), nausea, loss of appetite, unintended weight loss, increased heart rate (tachycardia), and dehydration. Some people develop swelling in their legs. The mouth may show changes, including a hyperemic (excessively red) oropharyngeal mucosa, geographic tongue, or fissured tongue.[2][5]
The symptoms of pustular psoriasis commonly appear in waves or flares. The condition may resolve for periods of time, only to resurface later triggered by one of the risk factors mentioned earlier. This unpredictable pattern of recurrence can be emotionally difficult for people living with the condition, as they never know when the next flare might occur or how severe it will be.[1][8]
Prevention
Currently, no known method can prevent someone from developing pustular psoriasis for the first time. The condition results from genetic predisposition and immune system dysfunction that cannot yet be prevented with existing medical knowledge. However, people already diagnosed with pustular psoriasis can take meaningful steps to reduce the frequency and severity of flares by managing known triggers.[1][10]
Understanding and avoiding personal triggers represents the most effective prevention strategy available. Since certain medications can provoke flares, people with pustular psoriasis should inform all their healthcare providers about their condition. Before starting any new medication—including over-the-counter drugs, supplements, or topical treatments—patients should discuss potential risks with their doctor or pharmacist. This includes being especially cautious with systemic corticosteroids, which should only be used when absolutely necessary and must be tapered extremely gradually under close medical supervision rather than stopped suddenly.[1]
Preventing and promptly treating infections helps reduce flare risk. This means practicing good hygiene, caring for cuts and scrapes properly to prevent bacterial infection, and seeking medical attention early when signs of infection appear. For people prone to fungal nail or skin infections, keeping these conditions well-controlled with appropriate antifungal treatment may help prevent pustular psoriasis episodes.[6]
Managing stress through relaxation techniques, regular exercise, adequate sleep, and professional counseling when needed may help reduce flare frequency. While stress cannot always be eliminated, learning healthier ways to cope with it appears to benefit many people with psoriasis. Avoiding excessive sun exposure and always using appropriate sun protection helps prevent sunburn-triggered flares. For people with palmoplantar pustular psoriasis, smoking cessation is particularly important, as smoking significantly increases the risk and severity of this form of the disease.[4][6]
Maintaining consistent treatment even during symptom-free periods helps prevent flares. Many people make the mistake of stopping their medications when their skin looks clear, only to experience a severe rebound flare. Working closely with a dermatologist to develop and stick to a long-term management plan provides the best chance of keeping pustular psoriasis under control. Some people find that keeping a detailed diary of flares—noting what they were eating, medications they were taking, stressors they were experiencing, and illnesses they had—helps identify personal triggers that can then be avoided.[1]
Pathophysiology
Understanding what happens inside the body during pustular psoriasis helps explain why symptoms develop and how treatments work. At the cellular level, the disease involves complex interactions between genetic factors, immune system components, and the skin’s structure. The normal function of skin depends on a carefully regulated balance of cell growth, immune surveillance, and inflammatory responses. In pustular psoriasis, multiple aspects of this balance go awry simultaneously.[11]
The genetic mutations associated with pustular psoriasis primarily affect genes involved in regulating the immune system’s inflammatory pathways. The IL36RN gene, when mutated, fails to produce adequate amounts of interleukin-36 receptor antagonist protein. This protein normally acts as a brake on inflammatory signaling. Without sufficient amounts of this brake mechanism, inflammatory signals cascade out of control. Other associated genes, including CARD14, AP1S3, MPO, and SERPINA3, similarly affect how cells communicate about inflammation and how the immune system responds to perceived threats.[6][13]
When pustular psoriasis becomes active, the immune system generates excessive amounts of inflammatory molecules called cytokines. These chemical messengers recruit huge numbers of white blood cells, particularly neutrophils, to the skin. Neutrophils are the immune cells primarily responsible for fighting bacterial infections, but in pustular psoriasis, they flood into the skin even though no infection exists. These neutrophils migrate from blood vessels in the dermis (the deeper skin layer) upward into the epidermis (the outermost skin layer).[3]
In the epidermis, neutrophils accumulate in spaces between skin cells called keratinocytes. They cluster together along with fluid, forming pockets between and within the keratinocyte layers. These collections are called spongiform pustules of Kogoj, a characteristic microscopic feature pathologists look for when examining skin biopsy samples. As more neutrophils accumulate, these microscopic pustules enlarge into the visible pustules that appear on the skin’s surface.[3][5]
The architecture of the skin itself undergoes significant changes during active disease. Like in plaque psoriasis, the epidermis shows elongation of structures called rete ridges—downward projections of the epidermis that normally interdigitate with the dermis. The very top layer of the epidermis thins over the dermal papillae (the upward projections of the dermis), creating a vulnerable area where pustules easily form. The normal process of skin cell maturation becomes disrupted, leading to parakeratosis—retention of cell nuclei in the outermost skin layer, where they shouldn’t normally be found.[3][5]
Blood vessels in the superficial dermis become dilated and surrounded by inflammatory cells. This increased blood flow to the skin’s surface causes the characteristic redness and heat that patients feel in affected areas. The inflammatory process damages the normal connections between skin cells, causing the spongiosis (intercellular swelling) that contributes to pustule formation and the eventual cracking and peeling of the skin surface.[5]
Beyond the skin, systemic inflammation affects multiple organ systems in people with generalized pustular psoriasis. Laboratory tests often reveal elevated levels of inflammatory markers including C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR). Complete blood counts show dramatic increases in white blood cells, sometimes reaching counts of 40,000 cells per microliter (normal is typically 4,000-11,000). Paradoxically, while total white blood cells increase, lymphocyte counts may actually decrease (lymphopenia). Blood chemistry tests may show decreased levels of albumin, calcium, and zinc, while liver enzymes (AST and ALT) may be elevated if the liver has been affected. Kidney function tests (blood urea nitrogen and creatinine) may be abnormal if the patient has become dehydrated. The loss of normal skin barrier function can lead to significant protein loss, electrolyte imbalances, and fluid depletion.[5][8]
The inflammation also affects the body’s ability to regulate temperature, explaining the fever that commonly accompanies generalized pustular psoriasis. The cardiovascular system responds to widespread inflammation by increasing heart rate. The metabolic demands of the inflammatory process increase caloric needs while simultaneously suppressing appetite, contributing to weight loss. Muscle weakness results from a combination of inflammation affecting muscle tissue, electrolyte imbalances, and the general catabolic (breakdown) state induced by severe systemic inflammation.[8]
Understanding these pathophysiological mechanisms has revolutionized treatment approaches. Rather than only treating surface symptoms, modern therapies target specific steps in the inflammatory cascade. Biologic medications that block interleukin pathways, for instance, work by preventing the inflammatory signaling that drives the entire disease process. This explains why newer treatments often prove more effective than older approaches that primarily focused on suppressing the immune system in general or treating only the skin’s surface.[11][12]
